Prevalence of psychiatric disorders in patients with chronic solvent induced encephalopathy (CSE)

NeuroToxicology

Volumn 32, Issue 6, 2011, Pages 916-922

  Visser, Ieke ^a   Wekking, Elizabeth M ^a   de Boer, Angela G E M ^b   de Joode, Elisabeth A ^c   van Hout, Moniek S E ^d   van Dorsselaer, Saskia ^e   Ruhé, Henricus G ^a   Huijser, Jochanan ^f   van der Laan, Gert ^a   van Dijk, Frank J H ^b   Schene, Aart H ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b Amsterdam Public Health research institute   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d MEDISCH SPECTRUM TWENTE   (Netherlands)

^e NETHERLANDS INSTITUTE OF MENTAL HEALTH AND ADDICTION   (Netherlands)

^f Arkin   (Netherlands)

Author keywords

Chronic solvent induced encephalopathy; DSM IV; Occupational health; Prevalence rates; Psychiatric disorders

Indexed keywords

SOLVENT;

ADULT; AGORAPHOBIA; ALCOHOL ABUSE; ANXIETY DISORDER; ARTICLE; BRAIN DISEASE; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; DISEASE SEVERITY; DYSTHYMIA; FEMALE; GENERALIZED ANXIETY DISORDER; HUMAN; LONG TERM EXPOSURE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL DISEASE; MOOD DISORDER; NEUROPSYCHOLOGICAL TEST; PANIC; PREVALENCE; PRIORITY JOURNAL; SUBSTANCE ABUSE;

ADULT; AFFECT; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; COGNITION; FEMALE; HUMANS; INHALATION EXPOSURE; MALE; MENTAL DISORDERS; MIDDLE AGED; NETHERLANDS; NEUROPSYCHOLOGICAL TESTS; NEUROTOXICITY SYNDROMES; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES; RISK ASSESSMENT; RISK FACTORS; SOLVENTS;

EID: 80055072950     PISSN: 0161813X     EISSN: 18729711     Source Type: Journal    
DOI: 10.1016/j.neuro.2011.05.001     Document Type: Article

References (54)

1. Abjornsson G., Pallson B., Burgendorf U., Karlson B., Osterberg K., Seger L., et al. Long term follow-up of psychological distress, social functioning, and coping style in treated and untreated patients with solvent induced chronic toxic encephalopathy. J Occup Environ Med 1998, 40:801-807.
2. Ashendorf L., Constantinou M., McCaffrey R.J. The effect of depression and anxiety on the TOMM in community-dwelling older adults. Arch Clin Neuropsychol 2001, 19:125-130.
3. Austin M.P., Mitchell P., Goodwin G.M. Cognitive deficits in depression. Possible implications for functional neuropathology. Br J Psychiatry 2001, 178:200-206.
4. Baker E.L., Letz A computer administered neurobehavioural evaluation system for occupational and environmental epidemiology. J Occup Med 1985, 206-212.
5. Baker E.L., Seppalainen A.M. Workshop on neurbehavioural effects of solvents. Human aspects of solvents neurobehavioural effects. Neurotoxicology 1986, 7:45-56.
6. Baker E.L. A review of recent research on health effects of human occupational exposure to organic solvents. A critical review. J Occup Environ Med 1994, 36:1079-1091.
7. Bast-Pettersen R. The neuropsychological diagnosis of chronic solvent induced encephalopathy (CSE) - a reanalysis of neuropsychological test results in a group of CSE patients diagnosed 20 years ago, based on comparisons with matched controls. Neurotoxicology 2009, 30:1195-1201.
8. Bijl R.V., Van Zessen G., Ravelli A., Rijk C.de, Langendoen Y. The Netherlands Mental Health Survey and Incidence Study (NEMESIS): objectives and design. Soc Psychiatry Psychiatr Epidemiol 1998, 33:581-586.
9. Binder L.M., Rohling M.L. Money matters: a meta-analytic review of the effects of financial incentives on recovery after closed-head injury. Am J Psychiatry 1996, 153:7-10.
10. Bolla K.I., Schwartz B.S., Agnew J., Ford P.D., Bleecker M.L. Subclinical neuropsychiatric effects of chronic low-level solvent exposure in US paint manufacturers. J Occup Environ Med 1990, 32:671.
11. Condray R., Morrow L.A., Steinhauer S.R., Hodgen M., Kelley M. Mood and behavioural symptoms in individuals with chronic solvent exposure. Psychiatry Res 2000, 97:191-206.
12. Elwood R.W. The Wechsler memory scale-revised: psychometric characteristics and clinical application. Neuropsychol Rev 1991, 2:179-201.
13. First M.B., Gibbon M., Spitzer R.L., Williams J.B.W. User guide for the structured clinical interview for DSM IV axis I disorders 1996, American Psychiatric Association, Washighton, DC.
14. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967, 278-296.
15. Haro J.M., Arbabadeh-Bouchez S., Brugha T.S., Girolamo G., Guyer M.E., Jin R., et al. Concordance of the Composite International Diagnostic Interview Version 3.0 (CIDI 3.0) with standardized clinical assessments in the WHO World Mental Health Surveys. Int J Methods Psychiatr Res 2006, 15:67-80.
16. Heaton R.K., Grant I., Matthews C.G. Differences in neuropsychological performance, associated with age, education and sex. Neuropsychological assessment of neuropsychiatric disorders 1986, Oxford University Press, New York.
17. Hoek J.A.F., van der, Verberk M.M., Laan G., van der, Hageman G. Chronische encefalopathie door oplosmiddelen; het 'solventteam'-project. Ned Tijdschr Geneeskd 2001, 145:256-260.
18. Hoek J.A.F., van der, Verberk M.M., Laan G., van der, Hageman G. A protocol for solvent induced CTE, 2 years of experience. Neurotoxicology 2000, 21:887.
19. van Hout M.S.E., Schmand B., Wekking E.M., Hageman G., Deelman B.G. Suboptimal performance on neuropsychological tests in patients with suspected chronic toxic encephalopathy. Neurotoxicology 2003, 24:547-551.
20. Kaplan J.S., Erickson K., Luckenbaugh D.A., Weiland-Fiedler P., Geraci M., Sahakian B.J., et al. Differential performance on tasks of affective processing and decision-making in patients with panic disorder and panic disorder with comorbid major depressive disorder. J Affect Disord 2006, 95:165-171.
21. Kaukiainen A., Riitta R., Martikainen R., Akila R., Reijula K., Sainno M. Solvent related effects among construction painters with decreasing exposure. Am J Ind Med 2004, 48:627-636.
22. Kessels R.P., Aleman A., Verhagen W.I., van Luijtelaar E.L. Cognitive functioning after whiplash injury: a meta-analysis. J Int Neuropsychol Soc 2000, 6:271-278.
23. Kiesswetter E., Sietman B., Seeber A. Standardization of a questionnaire for neurotoxic symptoms. Environ Res 1997, 73:73-80.
24. Kezic S., Calkoen F., Wenker M.A., Jacobs J.J., Verberk M.M. Genetic polymorphism of metabolic enzymes modifies the risk of chronic solvent-induced encephalopathy. Toxicol Ind Health 2006, 227:281-289.
25. Lieberman A. Depression in Parkinson's disease - a review. Acta Neurol Scand 2006, 113:1-8.
26. Lok E.Y., Mok C.C., Cheng C.W., Cheung E.F. Prevalence and determinants of psychiatric disorders in patients with rheumatoid arthritis. Psychosomatics 2010, 51:338-3388.
27. Luteijn F., van der Ploeg F.A.E. Groninger intelligentie test. Handleiding (manual) 1983, Swets and Zeitlinger, Lisse.
28. Morrow L.A., Ryan C.M., Hodgson M.J., Robin N. Alterations in cognitive and psychological functioning after organic solvent exposure. J Occup Med 1990, 32:444-450.
29. Morrow L.A., Kamis H., Hodgson M. Psychiatric symptomatology in persons with organic solvent exposure. J Consult Clin Psychol 1993, 61:171-174.
30. Morrow L.A., Gibon C., Bagovich G.R., Stein L., Condray R., Scott A. Increased incidence of anxiety and depressive disorders in persons with organic solvent exposure. Psychosom Med 2000, 62:746-750.
31. Mulder JL, Dekker R, Dekker PH. Verbale Leer en Geheugen Test (Dutch adaptation CVLT manual). Lisse: Swets & Zeitlinger; 1996.
32. Nordling Nilson L., Karlson B., Nise G., Malmberg B., Ørbæk P. Delayed manifestations of CNS effects in formerly exposed printers - a 20-year follow-up. Neurotoxicol Teratol 2010, 32:620-626.
33. Reiger D.A., Farmer M.E., Rae D.S., Locke B.Z., Keith S.J., Judd L.L., et al. Comorbidity of mental disorders with alcohol and drug abuse: results from the epidemiologic catchment area (ECA) study. JAMA 1990, 264:2511-2519.
34. Riise T., Kyvik K.R., Moen B. A cohort study of disability pensioning among Norwegian painters, construction workers, and workers in food processing. Epidemiology 1995, 6:132-136.
35. Sartorius N., Ustun T.B., Lecrubier Y., Wittchen H.U. Depression comorbid with anxiety: results from the WHO study results from the WHO study on psychological disorders in primary health care. Br J Psychiatry Suppl 1996, 30:38-43.
36. Schmand B., de Sterke S., Lindeboom J. The Amsterdam short-term memory test: manual 1999, Swets and Zeitlinger, Lisse.
37. Schmand B., Houx P., de Koning I. The stroop colour word test, the trail making test, the Rivermead behavioural memory test. Dutch norms 2004, Netherlands Institute of Psychologists, Section of Neuropsychology, Amsterdam.
38. Shear M.K., Bilt J., van der, Rucci P., Endicott J., Lydiard B., Otto M.W., et al. Reliability and validity of a structured interview guide for the Hamilton Anxiety Rating Scale (SIGH-A). Depress Anxiety 2001, 13:166-178.
39. Smeets R.M.W., Dingemans P.M.A.J. Composite International Diagnostic Interview (CIDI). Version 1.1 1993, Amsterdam, World Health Organization.
40. Tombaugh T.M. TOMM test of memory malingering: manual 1996, Multi Health Systems, Toronto.
41. Trivedi M.H., Rush A.J., Ibrahim H.M., Carmody T.J., Biggs M.M., Suppes T., et al. The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR) and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood-disorders: a psychometric evaluation. Psychol Med 2004, 34:73-82.
42. UK HSE. Health risks management: a guide to working with solvents HSG188. Sudburry: Health and Safety Executive; 1988.
43. US DHHS Publ No. 87-104. Cur Intell Bull 48. Organic solvent neurotoxicity. Cincinnati: USDHHS/PHS/CDC/NIOSH; 1987.
44. Visser RSH. Over het natekenen van de complxe figuur van Rey, een neuropsychologisch onderzoek. Thesis. Amsterdam: Swets en Zeitlinger; 1970.
45. Visser I., Lavini C., Booij J., Reneman L., Majoie C., de Boer A.G., et al. Cerebral impairment in chronic solvent-induced encephalopathy. Ann Neurol 2008, 63:572-580.
46. Warrington E.K. Recognition memory test: manual 1984, NFER-Nelson, Windsor, Berkshire.
47. Wechsler D. Wechsler adult intelligence scale-revised: manual 1981, The Psychological Corporation, Cleveland.
48. Werf S.P., van der, Prins J.P., Jongen P.J., Meer J.W., van der, Bleijenberg G. Abnormal neuropsychological findings are not necessarily a sign of cerebral impairment: a matched comparison between chronic fatigue syndrome and multiple sclerosis. Neuropsychiatry Neuropsychol Behav Neurol 2000, 13:199-203.
49. White R.F., Proctor S.P. Solvents and neurotoxicity. Lancet 1997, 349:1239-1243.
50. Wittchen H.U. Reliability and validity studies of the WHO Composite International Diagnostic Interview (CIDI): a critical review. J Psychiatr Res 1994, 28:57-84.
51. World Health Organization Chronic effects of organic solvents on the central nervous system and diagnostic criteria 1985, WHO, Copenhagen, p. 1-39 (Environmental Health 5).
52. World Health Organization Composite International Diagnostic Interview (CIDI). Version 1.0 1990, World Health Organization, Geneva.
53. Yadid G., Friedman A. Dynamics of the dopaminergic system as a key component to the understanding of depression. Prog Brain Res 2008, 172:265-286.
54. Yanez Y.T., Fremouw W., Tennant J., Strunk J., Coker K. Effects of severe depression on TOMM performance among disability-seeking outpatients. Arch Clin Neuropsychol 2006, 21:161-165.